Radovich Peter
PRESIDENT AND COO
Radovich Peter has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Jun 8, 2026.
On the most recent filing, Radovich Peter is listed as PRESIDENT AND COO at Mirum Pharmaceuticals, Inc. Inside the rolling window, Radovich Peter reported no open-market purchases and 4 open-market sales totaling $2.3M in MIRM. The largest disclosed transaction in the window is a sale of 16,515 MIRM shares on Mar 16, 2026, worth $1.5M.
Companies traded
Other insiders at MIRM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Radovich Peter made?
Radovich Peter has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company since 2026.
Which companies does Radovich Peter trade?
Radovich Peter has filed SEC Form 4 disclosures for 1 company, including MIRM.
When was Radovich Peter's most recent SEC Form 4 filing?
Radovich Peter's most recent SEC Form 4 filing on Tracefour is dated Jun 8, 2026.
What is Radovich Peter's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Radovich Peter is listed as PRESIDENT AND COO.
What is Radovich Peter's total buy and sell value in the current window?
Inside the rolling retention window, Radovich Peter bought $0 and sold $2.3M based on SEC Form 4 filings.
What was Radovich Peter's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 16,515 MIRM shares on 2026-03-16, worth $1.5M, per SEC Form 4 filings.